Tecentriq Advertiser Profile


Tecentriq
Cancer Prescription Drug
1 Dna Way, South San Francisco, CA US 94080
(650) 225-2500
MediaRadar 252 West 37th Street New York, NY 10018 855-723-2788
  • Ad Tech
  • Relevant Contact Info
  • View Recent Ad Creative
  • Media Spend
  • New Product Launches

Tecentriq is part of Roche Holding AG. They spent under $100 million on advertising in digital and print in the last year. They invest in premium ad units and advertised on under 50 different Media Properties in the last year across multiple Media formats. Tecentriq launched and advertised 1 new product in the past twelve months.

We have 18 people on file in marketing roles at Tecentriq, and 7 at their agencies.

Summary


Tecentriq is part of Roche Holding AG. They spent under $100 million on advertising in digital and print in the last year. They invest in premium ad units and advertised on under 50 different Media Properties in the last year across multiple Media formats. Tecentriq launched and advertised 1 new product in the past twelve months.

We have 18 people on file in marketing roles at Tecentriq, and 7 at their agencies.

MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 26 decision makers for you to contact at Tecentriq, including Executives, Strategists, Media Buyers and Agency contacts.


Will L.
United States Faricimab Lead, Ophthalmology

Renee W.
Co-Founder & Client Lead

Evan D.
Marketing Manager of Digital Marketing

Key Contacts


MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.

We have identified 26 decision makers for you to contact at Tecentriq, including Executives, Strategists, Media Buyers and Agency contacts.


Will L.
United States Faricimab Lead, Ophthalmology

Renee W.
Co-Founder & Client Lead

Evan D.
Marketing Manager of Digital Marketing

MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Tecentriq and its subsidiaries.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.

Recent Ad Creative


MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Tecentriq and its subsidiaries.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.
Print
Print
Last ran on Journal of Clinical Oncology in the 10/2020 issue.

MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Tecentriq Advertising Spend:
UNDER $100 Million
Increased Spending YoY

Media Spend


MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Tecentriq Advertising Spend:
UNDER $100 Million
Increased Spending YoY

MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 29,739 new product launches overall.
Tecentriq campaigns first seen Jul 2020.
Tecentriq launched a campaign supporting 1 new product line in the last twelve months, Tecentriq (Hepatocellular Carcinoma).

New Product Launches


MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 29,739 new product launches overall.
Tecentriq campaigns first seen Jul 2020.
Tecentriq launched a campaign supporting 1 new product line in the last twelve months, Tecentriq (Hepatocellular Carcinoma).